LaserSight seeks hyperopia indication for laser:
This article was originally published in Clinica
Executive Summary
LaserSight has filed a PMA supplement application to the US FDA for marketing approval to use its LaserScan LSX excimer laser system for performing LASIK treatments of hyperopia and hyperopic astigmatism. The Winter Park, Florida company filed a PMA supplement to use the laser in LASIK treatments of myopia and myopic astigmatism last year.